A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT00050830 · COMPLETED
Trial details
- NCT number
- NCT00050830
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.